{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,18]],"date-time":"2026-04-18T00:04:09Z","timestamp":1776470649698,"version":"3.51.2"},"reference-count":43,"publisher":"American Association for Cancer Research (AACR)","issue":"23","content-domain":{"domain":["aacrjournals.org"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2007,12,1]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>The c-myc oncogene plays a key role in cellular growth control, and translation initiation factors are among the transcriptional targets of Myc. Here, we describe a defect in translation initiation control in myc-null cells due to alterations in the mammalian target of rapamycin (mTOR) pathway. Myc loss increased sensitivity to dominant inhibition of eukaryotic translation initiation factor 4E function. Polysomal profiles of myc\u2212\/\u2212 cells revealed decreased translation initiation rates, which were accompanied by decreased 40S\/60S ribosomal subunit ratios. Because the 40S small ribosomal subunit contains the key regulatory ribosomal protein S6 (rpS6), we considered that myc loss might affect expression of components of the mTOR signaling pathway that regulate rpS6 function. Among mTOR signaling components, Myc directly affected transcription of tuberous sclerosis 2 (TSC2), as shown by quantitative mRNA analysis and by Myc binding to its promoter in chromatin immunoprecipitation assays. Importantly, Myc acted as a strong and direct repressor for TSC2 expression because its loss increased TSC2 mRNA in myc-null and in HL60 shRNA experiments, activation of a mycER construct in myc\u2212\/\u2212 cells suppressed TSC2 induction in a myc box II\u2013dependent manner, and mycER activation recruited Myc to the TSC2 promoter. The biological significance of the effect of Myc on TSC2 expression was shown by markedly reduced TSC2 mRNA levels in myc-transformed cells, stimulation of S6 kinase activity in myc-null cells by TSC2 siRNA, and decreased Myc-induced soft agar colony formation following retroviral transduction of TSC2. Together, these findings show that regulation of TSC2 can contribute to the effects of Myc on cell proliferation and neoplastic growth. [Cancer Res 2007;67(23):11209\u201317]<\/jats:p>","DOI":"10.1158\/0008-5472.can-06-4351","type":"journal-article","created":{"date-parts":[[2007,12,3]],"date-time":"2007-12-03T14:23:27Z","timestamp":1196691807000},"page":"11209-11217","update-policy":"https:\/\/doi.org\/10.1158\/crossmark_policy","source":"Crossref","is-referenced-by-count":47,"title":["c-myc Repression of\n                    <i>TSC2<\/i>\n                    Contributes to Control of Translation Initiation and Myc-Induced Transformation"],"prefix":"10.1158","volume":"67","author":[{"given":"Michael J.","family":"Ravitz","sequence":"first","affiliation":[{"name":"1Cancer Research Center at Massachusetts General Hospital and Harvard Medical School and"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Li","family":"Chen","sequence":"additional","affiliation":[{"name":"1Cancer Research Center at Massachusetts General Hospital and Harvard Medical School and"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mary","family":"Lynch","sequence":"additional","affiliation":[{"name":"1Cancer Research Center at Massachusetts General Hospital and Harvard Medical School and"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Emmett V.","family":"Schmidt","sequence":"additional","affiliation":[{"name":"1Cancer Research Center at Massachusetts General Hospital and Harvard Medical School and"},{"name":"2Department of Pediatrics, Harvard Medical School, Massachusetts General Hospital for Children, Boston, Massachusetts"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1086","published-online":{"date-parts":[[2007,12,3]]},"reference":[{"key":"2022061623221675400_B1","unstructured":"Baserga R. The biology of cell reproduction. Cambridge (MA): Harvard University Press; 1985."},{"key":"2022061623221675400_B2","doi-asserted-by":"crossref","unstructured":"Hahn WC, Dessain SK, Brooks MW, et al. Enumeration of the simian virus 40 early region elements necessary for human cell transformation. Mol Cell Biol\u20082002; 22: 2111\u201323.","DOI":"10.1128\/MCB.22.7.2111-2123.2002"},{"key":"2022061623221675400_B3","unstructured":"Sonenberg N, Hershey JWB, Mathews M, editors. Translational control of gene expression. 2nd ed. Cold Spring Harbor (NY): Cold Spring Harbor Laboratory Press; 2000."},{"key":"2022061623221675400_B4","doi-asserted-by":"crossref","unstructured":"Hay N, Sonenberg N. Upstream and downstream of mTOR. Genes Dev\u20082004; 18: 1926\u201345.","DOI":"10.1101\/gad.1212704"},{"key":"2022061623221675400_B5","doi-asserted-by":"crossref","unstructured":"Jones RM, Branda J, Johnston KA, et al. An essential E box in the promoter of the gene encoding the mRNA cap-binding protein (eukaryotic initiation factor 4E) is a target for activation by c-myc. Mol Cell Biol\u20081996; 16: 4754\u201364.","DOI":"10.1128\/MCB.16.9.4754"},{"key":"2022061623221675400_B6","doi-asserted-by":"crossref","unstructured":"Prathapam T, Tegen S, Oskarsson T, Trumpp A, Martin GS. Activated Src abrogates the Myc requirement for the G0\/G1 transition but not for the G1\/S transition. Proc Natl Acad Sci U S A\u20082006; 103: 2695\u2013700.","DOI":"10.1073\/pnas.0511186103"},{"key":"2022061623221675400_B7","doi-asserted-by":"crossref","unstructured":"Prochownik EV. c-Myc as a therapeutic target in cancer. Expert Rev Anticancer Ther\u20082004; 4: 289\u2013302.","DOI":"10.1586\/14737140.4.2.289"},{"key":"2022061623221675400_B8","doi-asserted-by":"crossref","unstructured":"Schmidt EV. The role of c-myc in regulation of translation initiation. Oncogene\u20082004; 23: 3217\u201321.","DOI":"10.1038\/sj.onc.1207548"},{"key":"2022061623221675400_B9","unstructured":"Mateyak MK, Obaya AJ, Adachi S, Sedivy JM. Phenotypes of c-Myc-deficient rat fibroblasts isolated by targeted homologous recombination. Cell Growth Differ\u20081997; 8: 1039\u201348."},{"key":"2022061623221675400_B10","doi-asserted-by":"crossref","unstructured":"Gingras AC, Raught B, Sonenberg N. eIF4 initiation factors: effectors of mRNA recruitment to ribosomes and regulators of translation. Annu Rev Biochem\u20081999; 68: 913\u201363.","DOI":"10.1146\/annurev.biochem.68.1.913"},{"key":"2022061623221675400_B11","doi-asserted-by":"crossref","unstructured":"Faivre S, Kroemer G, Raymond E. Current development of mTOR inhibitors as anticancer agents. Nat Rev Drug Discov\u20082006; 5: 671\u201388.","DOI":"10.1038\/nrd2062"},{"key":"2022061623221675400_B12","doi-asserted-by":"crossref","unstructured":"Hara K, Maruki Y, Long X, et al. Raptor, a binding partner of target of rapamycin (TOR), mediates TOR action. Cell\u20082002; 110: 177\u201389.","DOI":"10.1016\/S0092-8674(02)00833-4"},{"key":"2022061623221675400_B13","doi-asserted-by":"crossref","unstructured":"Shamji AF, Nghiem P, Schreiber SL. Integration of growth factor and nutrient signaling: implications for cancer biology. Mol Cell\u20082003; 12: 271\u201380.","DOI":"10.1016\/j.molcel.2003.08.016"},{"key":"2022061623221675400_B14","doi-asserted-by":"crossref","unstructured":"Wendel HG, De Stanchina E, Fridman JS, et al. Survival signalling by Akt and eIF4E in oncogenesis and cancer therapy. Nature\u20082004; 428: 332\u20137.","DOI":"10.1038\/nature02369"},{"key":"2022061623221675400_B15","doi-asserted-by":"crossref","unstructured":"Kwiatkowski DJ, Manning BD. Tuberous sclerosis: a GAP at the crossroads of multiple signaling pathways. Hum Mol Genet\u20082005; 14 Spec No. 2: R251\u20138.","DOI":"10.1093\/hmg\/ddi260"},{"key":"2022061623221675400_B16","doi-asserted-by":"crossref","unstructured":"Astrinidis A, Henske EP. Tuberous sclerosis complex: linking growth and energy signaling pathways with human disease. Oncogene\u20082005; 24: 7475\u201381.","DOI":"10.1038\/sj.onc.1209090"},{"key":"2022061623221675400_B17","doi-asserted-by":"crossref","unstructured":"Fingar DC, Richardson CJ, Tee AR, Cheatham L, Tsou C, Blenis J. mTOR controls cell cycle progression through its cell growth effectors S6K1 and 4E-BP1\/eukaryotic translation initiation factor 4E. Mol Cell Biol\u20082004; 24: 200\u201316.","DOI":"10.1128\/MCB.24.1.200-216.2004"},{"key":"2022061623221675400_B18","doi-asserted-by":"crossref","unstructured":"Tapon N, Ito N, Dickson BJ, Treisman JE, Hariharan IK. The Drosophila tuberous sclerosis complex gene homologs restrict cell growth and cell proliferation. Cell\u20082001; 105: 345\u201355.","DOI":"10.1016\/S0092-8674(01)00332-4"},{"key":"2022061623221675400_B19","doi-asserted-by":"crossref","unstructured":"Rosner M, Hofer K, Kubista M, Hengstschlager M. Cell size regulation by the human TSC tumor suppressor proteins depends on PI3K and FKBP38. Oncogene\u20082003; 22: 4786\u201398.","DOI":"10.1038\/sj.onc.1206776"},{"key":"2022061623221675400_B20","doi-asserted-by":"crossref","unstructured":"Li Z, Van Calcar S, Qu C, Cavenee WK, Zhang MQ, Ren B. A global transcriptional regulatory role for c-Myc in Burkitt's lymphoma cells. Proc Natl Acad Sci U S A\u20082003; 100: 8164\u20139.","DOI":"10.1073\/pnas.1332764100"},{"key":"2022061623221675400_B21","doi-asserted-by":"crossref","unstructured":"Soucek T, Pusch O, Wienecke R, DeClue JE, Hengstschlager M. Role of the tuberous sclerosis gene-2 product in cell cycle control. Loss of the tuberous sclerosis gene-2 induces quiescent cells to enter S phase. J Biol Chem\u20081997; 272: 29301\u20138.","DOI":"10.1074\/jbc.272.46.29301"},{"key":"2022061623221675400_B22","doi-asserted-by":"crossref","unstructured":"Lynch M, Fitzgerald C, Johnston KA, Wang S, Schmidt EV. Activated eIF4E-binding protein slows G1 progression and blocks transformation by c-myc without inhibiting cell growth. J Biol Chem\u20082004; 279: 3327\u201339.","DOI":"10.1074\/jbc.M310872200"},{"key":"2022061623221675400_B23","doi-asserted-by":"crossref","unstructured":"You Z, Madrid LV, Saims D, Sedivy J, Wang CY. c-Myc sensitizes cells to tumor necrosis factor-mediated apoptosis by inhibiting nuclear factor \u03baB transactivation. J Biol Chem\u20082002; 277: 36671\u20137.","DOI":"10.1074\/jbc.M203213200"},{"key":"2022061623221675400_B24","doi-asserted-by":"crossref","unstructured":"Lynch M, Chen L, Ravitz MJ, et al. hnRNP K binds a core polypyrimidine element in the eukaryotic translation initiation factor 4E (eIF4E) promoter, and its regulation of eIF4E contributes to neoplastic transformation. Mol Cell Biol\u20082005; 25: 6436\u201353.","DOI":"10.1128\/MCB.25.15.6436-6453.2005"},{"key":"2022061623221675400_B25","unstructured":"Meyuhas O, Blierman Y, Pierandrei-Amaldi P, Amaldi F. Analysis of polysomal RNA. In: Krieg P, editor. A laboratory guide to RNA: isolation, analysis and synthesis. New York (NY): Wiley Liss; 1996. p. 65\u201381."},{"key":"2022061623221675400_B26","doi-asserted-by":"crossref","unstructured":"Yamashita R, Suzuki Y, Wakaguri H, Tsuritani K, Nakai K, Sugano S. DBTSS: DataBase of Human Transcription Start Sites, progress report 2006. Nucleic Acids Res\u20082006; 34: D86\u20139.","DOI":"10.1093\/nar\/gkj129"},{"key":"2022061623221675400_B27","doi-asserted-by":"crossref","unstructured":"Loots GG, Ovcharenko I. rVISTA 2.0: evolutionary analysis of transcription factor binding sites. Nucleic Acids Res\u20082004; 32: W217\u201321.","DOI":"10.1093\/nar\/gkh383"},{"key":"2022061623221675400_B28","doi-asserted-by":"crossref","unstructured":"Kato GJ, Lee WM, Chen LL, Dang CV. Max: functional domains and interaction with c-Myc. Genes Dev\u20081992; 6: 81\u201392.","DOI":"10.1101\/gad.6.1.81"},{"key":"2022061623221675400_B29","doi-asserted-by":"crossref","unstructured":"Karbowniczek M, Cash T, Cheung M, Robertson GP, Astrinidis A, Henske EP. Regulation of B-Raf kinase activity by tuberin and Rheb is mammalian target of rapamycin (mTOR)-independent. J Biol Chem\u20082004; 279: 29930\u20137.","DOI":"10.1074\/jbc.M402591200"},{"key":"2022061623221675400_B30","doi-asserted-by":"crossref","unstructured":"Xu D, Popov N, Hou M, et al. Switch from Myc\/Max to Mad1\/Max binding and decrease in histone acetylation at the telomerase reverse transcriptase promoter during differentiation of HL60 cells. Proc Natl Acad Sci U S A\u20082001; 98: 3826\u201331.","DOI":"10.1073\/pnas.071043198"},{"key":"2022061623221675400_B31","doi-asserted-by":"crossref","unstructured":"Polymenis M, Schmidt EV. Coordination of cell growth with cell division. Curr Opin Genet Dev\u20081999; 9: 76\u201380.","DOI":"10.1016\/S0959-437X(99)80011-2"},{"key":"2022061623221675400_B32","doi-asserted-by":"crossref","unstructured":"Lazaris-Karatzas A, Montine KS, Sonenberg N. Malignant transformation by a eukaryotic initiation factor subunit that binds to mRNA 5\u2032 cap. Nature\u20081990; 345: 544\u20137.","DOI":"10.1038\/345544a0"},{"key":"2022061623221675400_B33","doi-asserted-by":"crossref","unstructured":"Ruggero D, Montanaro L, Ma L, et al. The translation factor eIF-4E promotes tumor formation and cooperates with c-Myc in lymphomagenesis. Nat Med\u20082004; 10: 484\u20136.","DOI":"10.1038\/nm1042"},{"key":"2022061623221675400_B34","doi-asserted-by":"crossref","unstructured":"Dang CV. c-Myc target genes involved in cell growth, apoptosis, and metabolism. Mol Cell Biol\u20081999; 19: 1\u201311.","DOI":"10.1128\/MCB.19.1.1"},{"key":"2022061623221675400_B35","doi-asserted-by":"crossref","unstructured":"Gera JF, Mellinghoff IK, Shi Y, et al. AKT activity determines sensitivity to mammalian target of rapamycin (mTOR) inhibitors by regulating cyclin D1 and c-myc expression. J Biol Chem\u20082004; 279: 2737\u201346.","DOI":"10.1074\/jbc.M309999200"},{"key":"2022061623221675400_B36","doi-asserted-by":"crossref","unstructured":"Hosoi H, Dilling MB, Liu LN, et al. Studies on the mechanism of resistance to rapamycin in human cancer cells. Mol Pharmacol\u20081998; 54: 815\u201324.","DOI":"10.1124\/mol.54.5.815"},{"key":"2022061623221675400_B37","doi-asserted-by":"crossref","unstructured":"Li LH, Nerlov C, Prendergast G, MacGregor D, Ziff EB. c-Myc represses transcription in vivo by a novel mechanism dependent on the initiator element and Myc box Ii. EMBO J\u20081994; 13: 4070\u20139.","DOI":"10.1002\/j.1460-2075.1994.tb06724.x"},{"key":"2022061623221675400_B38","doi-asserted-by":"crossref","unstructured":"Takano A, Usui I, Haruta T, et al. Mammalian target of rapamycin pathway regulates insulin signaling via subcellular redistribution of insulin receptor substrate 1 and integrates nutritional signals and metabolic signals of insulin. Mol Cell Biol\u20082001; 21: 5050\u201362.","DOI":"10.1128\/MCB.21.15.5050-5062.2001"},{"key":"2022061623221675400_B39","doi-asserted-by":"crossref","unstructured":"Zhang H, Cicchetti G, Onda H, et al. Loss of Tsc1\/Tsc2 activates mTOR and disrupts PI3K-Akt signaling through down-regulation of PDGFR. J Clin Invest\u20082003; 112: 1223\u201333.","DOI":"10.1172\/JCI200317222"},{"key":"2022061623221675400_B40","doi-asserted-by":"crossref","unstructured":"Henske EP. Metastasis of benign tumor cells in tuberous sclerosis complex. Genes Chromosomes Cancer\u20082003; 38: 376\u201381.","DOI":"10.1002\/gcc.10252"},{"key":"2022061623221675400_B41","doi-asserted-by":"crossref","unstructured":"Zhang XY, DeSalle LM, Patel JH, et al. Metastasis-associated protein 1 (MTA1) is an essential downstream effector of the c-MYC oncoprotein. Proc Natl Acad Sci U S A\u20082005; 102: 13968\u201373.","DOI":"10.1073\/pnas.0502330102"},{"key":"2022061623221675400_B42","doi-asserted-by":"crossref","unstructured":"Guccione E, Martinato F, Finocchiaro G, et al. Myc-binding-site recognition in the human genome is determined by chromatin context. Nat Cell Biol\u20082006; 8: 764\u201370.","DOI":"10.1038\/ncb1434"},{"key":"2022061623221675400_B43","doi-asserted-by":"crossref","unstructured":"Kim JW, Zeller KI, Wang Y, et al. Evaluation of myc E-box phylogenetic footprints in glycolytic genes by chromatin immunoprecipitation assays. Mol Cell Biol\u20082004; 24: 5923\u201336.","DOI":"10.1128\/MCB.24.13.5923-5936.2004"}],"container-title":["Cancer Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/aacrjournals.org\/cancerres\/article-pdf\/67\/23\/11209\/2576951\/11209.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/aacrjournals.org\/cancerres\/article-pdf\/67\/23\/11209\/2576951\/11209.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,6,16]],"date-time":"2022-06-16T23:04:05Z","timestamp":1655420645000},"score":1,"resource":{"primary":{"URL":"https:\/\/aacrjournals.org\/cancerres\/article\/67\/23\/11209\/533873\/c-myc-Repression-of-TSC2-Contributes-to-Control-of"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2007,12,1]]},"references-count":43,"journal-issue":{"issue":"23","published-online":{"date-parts":[[2007,12,3]]},"published-print":{"date-parts":[[2007,12,1]]}},"URL":"https:\/\/doi.org\/10.1158\/0008-5472.can-06-4351","relation":{"has-preprint":[{"id-type":"doi","id":"10.1158\/0008-5472.c.6496247","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/0008-5472.c.6496247.v1","asserted-by":"object"}],"is-supplemented-by":[{"id-type":"doi","id":"10.1158\/0008-5472.22370045","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/0008-5472.22370048.v1","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/0008-5472.22370045.v1","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/0008-5472.22370051","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/0008-5472.22370048","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/0008-5472.22370051.v1","asserted-by":"object"}]},"ISSN":["0008-5472","1538-7445"],"issn-type":[{"value":"0008-5472","type":"print"},{"value":"1538-7445","type":"electronic"}],"subject":[],"published":{"date-parts":[[2007,12,1]]}}}